Study of XPF-001 in the Treatment of Pain From Primary/Inherited Erythromelalgia (IEM)
Clinical trial NCT01090622 · COMPLETED
Trial details
- NCT number
- NCT01090622
- Sponsor
- Xenon Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2010-08-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.